αv integrin, p38 mitogen-activated protein kinase, and urokinase plasminogen activator are functionally linked in invasive breast cancer cells.

被引:48
作者
Chen, J
Baskerville, C
Han, QW
Pan, ZXK
Huang, S
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
关键词
D O I
10.1074/jbc.M107574200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We reported previously that endogenous p38 ALAPK activity is elevated in invasive breast cancer cells and that constitutive p38 MAPK activity is important for overproduction of uPA in these cells (Huang, S., New, L., Pan, Z., Han, J., and Nemerow, G. R. (2000) J. Biol. Chem. 275, 12266-12272). However, it is unclear how elevated endogenous p38 MAPK activity is maintained in invasive breast cancer cells. In the present study, we found that blocking a, integrin functionality with a function-blocking monoclonal antibody or down-regulating alpha (v) integrin expression with alpha (v)-specific antisense oligonucleotides significantly decreased the levels of active p38 MAPK and inhibited cell-associated uPA expression in invasive breast cancer MDA-ME-231 cells. These results suggest a function link between alpha (v) integrin, p38 MAPK activity, and uPA expression in invasive tumor cells. We also found that vitronectin/alpha (v) integrin ligation specifically induced p38 MAPK activation and uPA up-regulation in invasive MDA-MB-231 cells but not in non-invasive MCF7 cells. Finally, using a panel of melanoma cells, we demonstrated that the cytoplasmic tail of a, integrin subunit is required for alpha (v) integrin ligation-induced p38 MAPK activation.
引用
收藏
页码:47901 / 47905
页数:5
相关论文
共 69 条
  • [1] Effects of synthetic urokinase inhibitors on local invasion and metastasis in a murine mammary tumor model
    Alonso, DF
    Farias, EF
    Ladeda, V
    Davel, L
    Puricelli, L
    Joffe, EBD
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1996, 40 (03) : 209 - 223
  • [2] AZNAVOORIAN S, 1993, CANCER-AM CANCER SOC, V71, P1368, DOI 10.1002/1097-0142(19930215)71:4<1368::AID-CNCR2820710432>3.0.CO
  • [3] 2-L
  • [4] ANTIBODIES TO THE VITRONECTIN RECEPTOR (INTEGRIN ALPHA(V)BETA(3)) INHIBIT BINDING AND INFECTION OF FOOT-AND-MOUTH-DISEASE VIRUS TO CULTURED-CELLS
    BERINSTEIN, A
    ROIVAINEN, M
    HOVI, T
    MASON, PW
    BAXT, B
    [J]. JOURNAL OF VIROLOGY, 1995, 69 (04) : 2664 - 2666
  • [5] Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298
  • [6] Prognostic value of urokinase plasminogen activator in primary breast carcinoma:: comparison of two immunoassay methods
    Bouchet, C
    Spyratos, F
    Hacène, K
    Durcos, L
    Bécette, V
    Oglobine, J
    [J]. BRITISH JOURNAL OF CANCER, 1998, 77 (09) : 1495 - 1501
  • [7] REQUIREMENT OF VASCULAR INTEGRIN ALPHA(V)BETA(3) FOR ANGIOGENESIS
    BROOKS, PC
    CLARK, RAF
    CHERESH, DA
    [J]. SCIENCE, 1994, 264 (5158) : 569 - 571
  • [8] Carriero MV, 1999, CANCER RES, V59, P5307
  • [9] Osteopontin activation of c-src in human melanoma cells requires the cytoplasmic domain of the integrin alpha(v)-subunit
    Chellaiah, M
    Fitzgerald, C
    Filardo, EJ
    Cheresh, DA
    Hruska, KA
    [J]. ENDOCRINOLOGY, 1996, 137 (06) : 2432 - 2440
  • [10] STRUCTURE, FUNCTION AND BIOLOGICAL PROPERTIES OF INTEGRIN ALPHA-V-BETA-3 ON HUMAN-MELANOMA CELLS
    CHERESH, DA
    [J]. CANCER AND METASTASIS REVIEWS, 1991, 10 (01) : 3 - 10